Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin

CONTEXT: Patients with diabetes often have comorbidities such as hypertension. It is not known how individual characteristics influence response to dipeptidyl peptidase-4 (DPP4) inhibitors. OBJECTIVE: We tested the hypothesis that individual characteristics, sitagliptin dose, and genetic variability...

Full description

Saved in:
Bibliographic Details
Published in:J Endocr Soc
Main Authors: Wilson, Jessica R., Shuey, Megan M., Brown, Nancy J., Devin, Jessica K.
Format: Artigo
Language:Inglês
Published: Endocrine Society 2017
Subjects:
Clinical Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686657/
https://ncbi.nlm.nih.gov/pubmed/29264572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2017-00312
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items